View in EDS HTML Full Text PDF Full Text

Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema.

Saved in:
Bibliographic Details
Title: Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema.
Authors: Adán-Castro, Elva1 (AUTHOR), Zamora, Magdalena1 (AUTHOR), Granados-Carrasco, Daniela1 (AUTHOR), Siqueiros-Márquez, Lourdes1 (AUTHOR), García-Rodrigo, Jose F.1 (AUTHOR), Macias, Fernando1 (AUTHOR), Bertsch, Thomas2 (AUTHOR), Triebel, Jakob2 (AUTHOR), Arnold, Edith1,3 (AUTHOR), Martínez de la Escalera, Gonzalo1 (AUTHOR), Robles, Juan Pablo1,4 (AUTHOR) jp.robles@viantx.com, Clapp, Carmen1 (AUTHOR) clapp@unam.mx
Source: Scientific Reports. 7/23/2025, Vol. 15 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-12331-w